|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
9315
|
|
pubmed:dateCreated |
2002-4-29
|
|
pubmed:abstractText |
The efficacy of BCG vaccines against pulmonary tuberculosis varies between populations, showing no protection in Malawi but 50-80% protection in the UK. To investigate the mechanism underlying these differences, randomised controlled studies were set up to measure vaccine-induced immune responsiveness to mycobacterial antigens in both populations.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
0140-6736
|
|
pubmed:author |
pubmed-author:BlackGillian FGF,
pubmed-author:BlackwellJenefer MJM,
pubmed-author:BlissLynL,
pubmed-author:BransonKeithK,
pubmed-author:ChagulukaSteven DSD,
pubmed-author:CrampinAmelia CAC,
pubmed-author:DockrellHazel MHM,
pubmed-author:DonovanLindaL,
pubmed-author:FinePaul E MPE,
pubmed-author:FloydSianS,
pubmed-author:JarmanElizabethE,
pubmed-author:KingElizabethE,
pubmed-author:NazarethBernadetteB,
pubmed-author:NgwiraBagreyB,
pubmed-author:SichaliLiftedL,
pubmed-author:WarndorffDavid KDK,
pubmed-author:WeirRosemary ERE
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
20
|
|
pubmed:volume |
359
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1393-401
|
|
pubmed:dateRevised |
2008-11-21
|
|
pubmed:meshHeading |
pubmed-meshheading:11978337-Adolescent,
pubmed-meshheading:11978337-Adult,
pubmed-meshheading:11978337-BCG Vaccine,
pubmed-meshheading:11978337-Female,
pubmed-meshheading:11978337-Great Britain,
pubmed-meshheading:11978337-Humans,
pubmed-meshheading:11978337-Interferon-gamma,
pubmed-meshheading:11978337-Malawi,
pubmed-meshheading:11978337-Male,
pubmed-meshheading:11978337-Mycobacterium tuberculosis,
pubmed-meshheading:11978337-Tuberculin,
pubmed-meshheading:11978337-Tuberculin Test,
pubmed-meshheading:11978337-Tuberculosis
|
|
pubmed:year |
2002
|
|
pubmed:articleTitle |
BCG-induced increase in interferon-gamma response to mycobacterial antigens and efficacy of BCG vaccination in Malawi and the UK: two randomised controlled studies.
|
|
pubmed:affiliation |
Karonga Prevention Study, Chilumba, Malawi.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
